Loading...
01/10 18:47
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture: revenue decreased by 7% YoY, but gross profit and adjusted EBITDA improved. The cannabis industry's potential reclassification is a positive long-term catalyst, but short-term financial guidance is not strong. Operating expenses decreased significantly, yet the backlog also fell. The Q&A revealed cautious optimism about cannabis rescheduling but no immediate impact. Overall, the financial results are mixed with some positive developments, leading to a neutral sentiment.
Revenue $15.5 million, a decrease of $1.2 million or 7% year-over-year from $16.8 million, driven by a $0.4 million decrease in construction design-build revenue, a $0.4 million decrease in equipment systems revenue, and a $0.3 million decrease in services revenue.
Gross Profit $3.1 million or 20% of revenue, an increase from $2.1 million or 17% of revenue year-over-year, driven by improved margins in services and construction design-build revenues.
Operating Expenses $5.2 million, a decrease of $2.7 million or 34% year-over-year from $7.9 million, attributed to the company's expense optimization and resource reallocation initiative.
Net Loss $2.1 million or a negative $0.18 per diluted share, an improvement from a net loss of $5.1 million or a negative $0.48 per diluted share year-over-year.
Adjusted EBITDA Negative $0.3 million, an improvement of $3.1 million year-over-year, driven by lower operating expenses.
Backlog $99 million, a decrease of $11 million or 10% sequentially, with 76% from the CYA sector and 24% from the commercial sector.
Market Positioning: The US Drug Enforcement Agency is supporting the Department of Health recommendation to reclassify cannabis from Schedule I to Schedule III, which is expected to provide a catalyst for the cannabis industry.
Market Expansion: Urban-gro is actively engaged with clients in multiple fronts in the cannabis sector, anticipating steady activity and continued signing of services and construction contracts.
Market Trends: Approximately 72% of revenues in Q1 2024 came from commercial sectors, indicating a diversification strategy that has insulated the business from headwinds in the cannabis sector.
State-Level Developments: Progress continues on legalization in multiple states, with Florida's adult-use recreational sales on the ballot in November, which could significantly impact urban-gro.
Operational Efficiency: Urban-gro reported positive cash flow from operations and the strongest quarterly adjusted EBITDA results in two years, attributed to diversified revenue streams and reduced operating expenses.
Cost Reduction: The company realized a $2.8 million improvement in adjusted EBITDA compared to Q1 2023, driven by an $8 million reduction in general and administrative expenses.
Backlog: Urban-gro's backlog remains strong at $99 million, with 76% from the Controlled Environment Agriculture sector.
Strategic Shift: Urban-gro is maintaining its guidance for over $84 million in revenue and positive adjusted EBITDA for the full year 2024, despite uncertainties related to cannabis rescheduling.
Regulatory Risks: The company faces uncertainties related to the timing and final approval of cannabis rescheduling, which could impact operational strategies and market conditions.
Market Sentiment: Despite recent positive developments, operators in the cannabis sector are exhibiting cautious optimism, indicating potential volatility in market conditions.
Supply Chain Challenges: The company is experiencing persistent state-level regulatory and legal delays that could affect project timelines and operational efficiency.
Economic Factors: The company is navigating through various macroeconomic scenarios, which could impact financial performance and operational flexibility.
Backlog Decrease: The total backlog decreased by $11 million or 10% sequentially, indicating potential challenges in securing new projects.
Revenue Decrease: There was a year-over-year revenue decrease of $1.2 million or 7%, driven by a downturn in the cannabis industry affecting construction and service revenues.
Backlog: The total backlog as of March 31, 2024, was approximately $99 million, reflecting a decrease of $11 million or 10% on a sequential basis.
Revenue Diversification: In the first quarter, approximately 72% of revenues came from the commercial sectors, while 28% came from Controlled Environment Agriculture (CEA).
Revenue Guidance: For full year 2024, the company is maintaining its guidance to recognize more than $84 million in revenue.
Adjusted EBITDA Guidance: The company expects to generate positive adjusted EBITDA for the full year 2024.
Market Outlook: The successful rescheduling of cannabis is anticipated to reinvigorate the industry, potentially increasing working capital for cannabis operators.
Federal and State Developments: Prospects of passing a banking-related bill by year-end and legalization efforts in states like Florida could significantly impact urban-gro's business.
Shareholder Return Plan: urban-gro has not announced any share buyback or dividend program during the call.
The earnings call presents a mixed picture: revenue decreased by 7% YoY, but gross profit and adjusted EBITDA improved. The cannabis industry's potential reclassification is a positive long-term catalyst, but short-term financial guidance is not strong. Operating expenses decreased significantly, yet the backlog also fell. The Q&A revealed cautious optimism about cannabis rescheduling but no immediate impact. Overall, the financial results are mixed with some positive developments, leading to a neutral sentiment.
The earnings call reveals several concerns: negative EBITDA widening to $9.7 million, project delays, and cost revisions. Despite a 40% increase in backlog, uncertainties remain, especially with the CEA sector's underperformance. Management's vague responses on mitigating delays and capitalizing on legislative catalysts further dampen sentiment. The reduced breakeven point and diversification efforts are positives, but the overall outlook is clouded by challenges in equipment demand and European operations. Without clear guidance or a new partnership, the stock is likely to experience a negative reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
